Congratulations to two amazing physicians who treat Neuroendocrine Tumor patients upon being selected for the 2020 40 Under 40 in Cancer: Arturo Loaiza-Bonilla, MD, Gastrointestinal Program Director and Medical Director of Clinical Research at Cancer Treatment Centers of America in Philadelphia, where he also serves as the hospital’s Chief of Medical Oncology and Medical Director of Research, and Namrata Vijayvergia, MD, Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer Center in Philadelphia and Medical Director, Medical Oncology for Fox Chase Cancer Center Partners. 40 Under 40 in Cancer is an awards initiative to identify and recognize the contributions being made across the field of cancer by rising stars and emerging leaders under the age of 40 years. Finalists and awardees will be selected by a panel of reviewers from across diverse roles in oncology.

Newly published articles of interest to the NET community include:

• Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients? Co-authors of this article include NET experts Aman Chauhan, MD and Lowell Anthony, MD of UK Markey Cancer Center and Satya Das, MD and Robert Ramirez, DO of Vanderbilt-Ingram Cancer Center.
  
  
• Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors. This review article is co-authored by Satya Das, MD of Vanderbilt University Medical Center and Arvind Dasari, MD of MD Anderson Cancer Center.
  
  
• Newly published consensus guidelines from NANETS, 2021 The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.

Register now for one or more of three upcoming NET patient virtual conferences:

• Los Angeles Neuroendocrine Tumor Patient Education Virtual Conference on Saturday, June 19, 2021

• CNETS Canada Virtual NET Patient Conference, Saturday, June 19 and Sunday, June 20, 2021

• NANETS Western NET Patient Virtual Conference (all NET patients are welcome to register), Saturday, June 26, 2021

Advanced Accelerator Applications (AAA) has expanded its financial assistance programs for NET patients who are treated with Lutathera. For more information about AAA PatientCONNECT, visit www.aaapatientconnect.com and click on Patient Access Support or call 1-844-638-7222.